Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEXT Starts Full Discussions to Promote iPS Cell Research
January 28, 2008
- Gov't and Drug-Related Hepatitis Victims Agree on Settlement
January 28, 2008
- Korosho, MEXT, METI to Work Together to Promote iPS Cell Research
January 28, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 28, 2008
- Guidance to Promote Use of EDC Prepared by the JPMA
January 28, 2008
- TOPICS／PMDA Chief Executive Akira Miyajima Resigns
January 28, 2008
- Novartis to Step Back from Development of Vildagliptin in US
January 28, 2008
- Mundipharma to Focus on Pain and Cancer
January 28, 2008
- WG Proposes New Rule on Participation of Council Members with COI
January 28, 2008
- Takeda to Place Top Priority on Early Approval of SYR-322 and TAK-390MR: President Hasegawa
January 28, 2008
- REGULATORY NEWS IN BRIEF
January 28, 2008
- Kissei Licenses Treatment for ALI/ARDS from Pneuma Partners
January 28, 2008
- STATISTICS
January 28, 2008
- Merger with Ain Pharmaciez Is the Best Option for CFS: President Ishida
January 28, 2008
- OTC Drugs Help Cut Medical Expenditures: JSMI President Mr Miwa
January 28, 2008
- Why is Our Brand Underperforming against Expectations?
January 28, 2008
- JPA, JSMI to Regularly Exchange Opinions on Class 1 OTC Drugs
January 28, 2008
- TOPICS／J&J to Advertise Nicorette in Taxis
January 28, 2008
- TOPICS／T. Dooley Elected Chairman of Japan Intraocular Lens Association
January 28, 2008
- GENERICS NEWS IN BRIEF
January 21, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…